Literature DB >> 28137752

Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.

Jesper Holst Pedersen1, Witold Rzyman2, Giulia Veronesi3, Thomas A D'Amico4, Paul Van Schil5, Laureano Molins6, Gilbert Massard7, Gaetano Rocco8.   

Abstract

In order to provide recommendations regarding implementation of computed tomography (CT) screening in Europe the ESTS established a working group with eight experts in the field. On a background of the current situation regarding CT screening in Europe and the available evidence, ten recommendations have been prepared that cover the essential aspects to be taken into account when considering implementation of CT screening in Europe. These issues are: (i) Implementation of CT screening in Europe, (ii) Participation of thoracic surgeons in CT screening programs, (iii) Training and clinical profile for surgeons participating in screening programs, (iv) the use of minimally invasive thoracic surgery and other relevant surgical issues and (v) Associated elements of CT screening programs (i.e. smoking cessation programs, radiological interpretation, nodule evaluation algorithms and pathology reports). Thoracic Surgeons will play a key role in this process and therefore the ESTS is committed to providing guidance and facilitating this process for the benefit of patients and surgeons.
© The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  CT screening ; Implementation; Lung Cancer ; Recommendations

Mesh:

Year:  2017        PMID: 28137752      PMCID: PMC6279064          DOI: 10.1093/ejcts/ezw418

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  97 in total

1.  Surgery versus SABR for resectable non-small-cell lung cancer.

Authors:  Isabelle Opitz; Gaetano Rocco; Alessandro Brunelli; Gonzalo Varela; Gilbert Massard; Walter Weder
Journal:  Lancet Oncol       Date:  2015-08       Impact factor: 41.316

Review 2.  CT screening for lung cancer: Is the evidence strong enough?

Authors:  J K Field; A Devaraj; S W Duffy; D R Baldwin
Journal:  Lung Cancer       Date:  2015-11-30       Impact factor: 5.705

3.  Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database.

Authors:  Subroto Paul; Nasser K Altorki; Shubin Sheng; Paul C Lee; David H Harpole; Mark W Onaitis; Brendon M Stiles; Jeffrey L Port; Thomas A D'Amico
Journal:  J Thorac Cardiovasc Surg       Date:  2010-02       Impact factor: 5.209

4.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

5.  Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.

Authors:  Nanda Horeweg; Carlijn M van der Aalst; Erik Thunnissen; Kristiaan Nackaerts; Carla Weenink; Harry J M Groen; Jan-Willem J Lammers; Joachim G Aerts; Ernst T Scholten; Joost van Rosmalen; Willem Mali; Matthijs Oudkerk; Harry J de Koning
Journal:  Am J Respir Crit Care Med       Date:  2013-04-15       Impact factor: 21.405

6.  Performance of ACR Lung-RADS in a clinical CT lung screening program.

Authors:  Brady J McKee; Shawn M Regis; Andrea B McKee; Sebastian Flacke; Christoph Wald
Journal:  J Am Coll Radiol       Date:  2014-08-28       Impact factor: 5.532

7.  Persistent pure ground-glass opacity lung nodules ≥ 10 mm in diameter at CT scan: histopathologic comparisons and prognostic implications.

Authors:  Hyun-Ju Lim; Soomin Ahn; Kyung Soo Lee; Joungho Han; Young Mog Shim; Sookyoung Woo; Jae-Hun Kim; Miyeon Yie; Ho Yun Lee; Chin A Yi
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

8.  The impact of hospital and surgeon volume on the 30-day mortality of lung cancer surgery: A nation-based reappraisal.

Authors:  Pierre-Emmanuel Falcoz; Marc Puyraveau; Caroline Rivera; Alain Bernard; Gilbert Massard; Frederic Mauny; Marcel Dahan; Pascal-Alexandre Thomas
Journal:  J Thorac Cardiovasc Surg       Date:  2014-01-25       Impact factor: 5.209

9.  Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.

Authors:  David S Gierada; Paul Pinsky; Hrudaya Nath; Caroline Chiles; Fenghai Duan; Denise R Aberle
Journal:  J Natl Cancer Inst       Date:  2014-10-18       Impact factor: 13.506

10.  UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.

Authors:  J K Field; S W Duffy; D R Baldwin; D K Whynes; A Devaraj; K E Brain; T Eisen; J Gosney; B A Green; J A Holemans; T Kavanagh; K M Kerr; M Ledson; K J Lifford; F E McRonald; A Nair; R D Page; M K B Parmar; D M Rassl; R C Rintoul; N J Screaton; N J Wald; D Weller; P R Williamson; G Yadegarfar; D M Hansell
Journal:  Thorax       Date:  2015-12-08       Impact factor: 9.139

View more
  18 in total

Review 1.  Quality assurance and quantitative imaging biomarkers in low-dose CT lung cancer screening.

Authors:  Chara E Rydzak; Samuel G Armato; Ricardo S Avila; James L Mulshine; David F Yankelevitz; David S Gierada
Journal:  Br J Radiol       Date:  2017-10-27       Impact factor: 3.039

Review 2.  The 8th TNM edition for lung cancer: a critical analysis.

Authors:  Paul E Van Schil; Ramon Rami-Porta; Hisao Asamura
Journal:  Ann Transl Med       Date:  2018-03

Review 3.  Low-Dose CT Screening for Lung Cancer: Evidence from 2 Decades of Study.

Authors:  David S Gierada; William C Black; Caroline Chiles; Paul F Pinsky; David F Yankelevitz
Journal:  Radiol Imaging Cancer       Date:  2020-03-27

4.  Preoperative radio-guided localization of lung nodules with I-125 seeds: experience with 32 patients at a single institution.

Authors:  Sara Fra-Fernández; Luis Gorospe-Sarasúa; Odile Ajuria-Illarramendi; Percy Enrique Serrano-Carvajal; Gemma María Muñoz-Molina; Alberto Cabañero-Sánchez; Maria Eugenia Rioja-Martin; Nicolás Moreno-Mata
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-08-11

5.  Multiomics Analysis Reveals Distinct Immunogenomic Features of Lung Cancer with Ground-Glass Opacity.

Authors:  Kezhong Chen; Jing Bai; Alexandre Reuben; Heng Zhao; Guannan Kang; Chunliu Zhang; Qingyi Qi; Yaping Xu; Shawna Hubert; Lianpeng Chang; Yanfang Guan; Lin Feng; Kai Zhang; Kaitai Zhang; Xin Yi; Xuefeng Xia; Shujun Cheng; Fan Yang; Jianjun Zhang; Jun Wang
Journal:  Am J Respir Crit Care Med       Date:  2021-11-15       Impact factor: 21.405

Review 6.  Recent advances in the management of non-small cell lung cancer.

Authors:  Samira Shojaee; Patrick Nana-Sinkam
Journal:  F1000Res       Date:  2017-12-07

7.  Geographical Variation and Factors Associated with Non-Small Cell Lung Cancer in Manitoba.

Authors:  David E Dawe; Harminder Singh; Lahiru Wickramasinghe; Marshall W Pitz; Mahmoud Torabi
Journal:  Can Respir J       Date:  2017-06-21       Impact factor: 2.409

Review 8.  Non-small cell lung cancer: the new T1 categories.

Authors:  Paul E Van Schil
Journal:  F1000Res       Date:  2017-02-22

9.  A national survey of lung cancer specialists' views on low-dose CT screening for lung cancer in Korea.

Authors:  Dong Wook Shin; Sohyun Chun; Young Il Kim; Seung Joon Kim; Jung Soo Kim; SeMin Chong; Young Sik Park; Sang-Yun Song; Jin Han Lee; Hee Kyung Ahn; Eun Young Kim; Sei Hoon Yang; Myoung Kyu Lee; Deog Gon Cho; Tae Won Jang; Ji Woong Son; Jeong-Seon Ryu; Moon-June Cho
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

10.  GalNAc-T3 and MUC1, a combined predictor of prognosis and recurrence in solitary pulmonary adenocarcinoma initially diagnosed as malignant solitary pulmonary nodule (≤ 3 cm).

Authors:  Qiang Xie; Fengzhou Li; Shilei Zhao; Tao Guo; Zhuoshi Li; Lei Fang; Shiqing Wang; Wenzhi Liu; Chundong Gu
Journal:  Hum Cell       Date:  2020-08-10       Impact factor: 4.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.